Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Rivera

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|July 17, 2023
Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factorsAnna Gueiderikh, Thomas Sarrade, Youlia Kirova, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|November 16, 2025
Validation of DICOM extraction and Structuration Toolkit (DEST) for automated extraction and structuration of radiotherapy data for large-scale analysisIbrahima Diallo, Mamadou Hady Balde, Duyen Do, et al.
Technical Innovations & Patient Support in Radiation Oncology|April 13, 2026
Dosimetric comparison of the shoulder region between paired photon and proton plans in breast cancer patientsYuqin Liang, Karolien Verhoeven, Gloria Vilches-Freixas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2015
First results of the preoperative accelerated partial breast irradiation (PAPBI) trialFemke van der Leij, Sophie C J Bosma, Marc J van de Vijver, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 1, 2025
Evolution of radiation oncology training in France: Over 20 years of the role of the Société française des jeunes radiothérapeutes oncologues (SFjRO, the French society of young radiation oncologists)Audrey Larnaudie, Youssef Ghannam, Yasmine El Houat, et al.
Cancer|June 18, 2016
Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609)Florence Lerebours, Sofia Rivera, Marie-Ange Mouret-Reynier, et al.
Critical Reviews in Oncology/Hematology|May 26, 2020
The 2018 assisi think tank meeting on breast cancer: International expert panel white paperMeritxell Arenas, Ugur Selek, Orit Kaidar-Person, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 24, 2026
Enhancing heart and lung dose reconstruction in breast cancer radiotherapy using publicly available out-of-field dose profilesIbrahima Diallo, Mamadou Hady Balde, Véronique Letort, et al.
British Journal of Cancer|February 1, 2020
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trialsFlorence Lerebours, Marina Pulido, Emmanuelle Fourme, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 17, 2025
Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trialThomas Brion, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|July 17, 2023
Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factorsAnna Gueiderikh, Thomas Sarrade, Youlia Kirova, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|November 16, 2025
Validation of DICOM extraction and Structuration Toolkit (DEST) for automated extraction and structuration of radiotherapy data for large-scale analysisIbrahima Diallo, Mamadou Hady Balde, Duyen Do, et al.
Technical Innovations & Patient Support in Radiation Oncology|April 13, 2026
Dosimetric comparison of the shoulder region between paired photon and proton plans in breast cancer patientsYuqin Liang, Karolien Verhoeven, Gloria Vilches-Freixas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2015
First results of the preoperative accelerated partial breast irradiation (PAPBI) trialFemke van der Leij, Sophie C J Bosma, Marc J van de Vijver, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 1, 2025
Evolution of radiation oncology training in France: Over 20 years of the role of the Société française des jeunes radiothérapeutes oncologues (SFjRO, the French society of young radiation oncologists)Audrey Larnaudie, Youssef Ghannam, Yasmine El Houat, et al.
Cancer|June 18, 2016
Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609)Florence Lerebours, Sofia Rivera, Marie-Ange Mouret-Reynier, et al.
Critical Reviews in Oncology/Hematology|May 26, 2020
The 2018 assisi think tank meeting on breast cancer: International expert panel white paperMeritxell Arenas, Ugur Selek, Orit Kaidar-Person, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 24, 2026
Enhancing heart and lung dose reconstruction in breast cancer radiotherapy using publicly available out-of-field dose profilesIbrahima Diallo, Mamadou Hady Balde, Véronique Letort, et al.
British Journal of Cancer|February 1, 2020
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trialsFlorence Lerebours, Marina Pulido, Emmanuelle Fourme, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 17, 2025
Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trialThomas Brion, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Pageof 8